Helius Medical Technologies, Inc. announces that it has agreed to advance NeuroHabilitation Corp. a bridge loan in the amount of US $150,000 in connection with the proposed acquisition announced in a previous news release dated May 30, 2014. The Bridge Loan is for a term of one year commencing on the date of advance and is payable in a lump sum at the end of the term. The Bridge Loan bears interest at a rate of 8% per annum.
For further information, please contact:
Marco Babini at 778-881-3232
CAUTIONARY DISCLAIMER STATEMENT: The Company is a reporting issuer in the provinces of British Columbia and Alberta and not listed on any stock exchange. No stock exchange nor any regulation services provider accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.